Premium
Adenosine and synaptic plasticity
Author(s) -
de Mendonça Alexandre,
Ribeiro Joachim A.
Publication year - 2001
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.1125
Subject(s) - metaplasticity , synaptic plasticity , long term potentiation , neuroscience , adenosine , adenosinergic , adenosine receptor , nonsynaptic plasticity , synaptic fatigue , homosynaptic plasticity , long term depression , synaptic scaling , adenosine a1 receptor , purinergic signalling , chemistry , inhibitory postsynaptic potential , psychology , nmda receptor , receptor , excitatory postsynaptic potential , ampa receptor , agonist , biochemistry
Adenosine modulates long‐term synaptic plasticity. Application of adenosine A 1 receptor agonists attenuates long‐term potentiation (LTP) in the hippocampus. Endogenous adenosine exerts a tonic inhibitory effect on LTP, since A 1 receptor antagonists consistently facilitate LTP. Adenosine also modulates the reciprocal phenomenon of synaptic plasticity, long‐term depression (LTD), and depotentiation in a way that depends on the specific induction protocol. Application of adenosine A 2A receptor agonists can facilitate LTP, but the role of endogenous adenosine mediated through A 2A receptors in the modulation of synaptic plasticity is still the subject of controversy. The effects of adenosine on synaptic plasticity mediated through A 3 receptors have been described. In accordance with the notion that synaptic plasticity is the basis for learning and memory in different brain areas, adenosine correspondingly modulates behavior in various learning and memory paradigms. The effects of adenosine on synaptic plasticity should be relevant for the enhancement of intellectual performance related to caffeine intake. Adenosinergic compounds might prove helpful in the treatment of memory disorders. Drug Dev. Res. 52:283–290, 2001. © 2001 Wiley‐Liss, Inc.